4 European Projects Found
Searched on 125080 European Projects
FINISHED
nEUROinflammation
Start date: Oct 1, 2013, End date: Sep 30, 2017,
Neuroinflammation is a hallmark of multiple sclerosis and ischemic stroke. Investigating neuroinflammation as a common theme in neurological disorders, this ITN will focus in particular on myeloid cells, microglia, and endothelial cells. Sixteen partners from the academic and private sector with complementary scientific background join forces to train 13 ESRs in neuroinflammatory concepts and tech ...
Read Project
13
Partners Participants
FINISHED
European Patients' Academy on Therapeutic Innovation (EUPATI)
Start date: Feb 1, 2012, End date: Jan 31, 2017,
"The proposed project ""European Patients' Academy on Therapeutic Innovation"" (EUPATI) contributes to IMI’s goal of raising patients’ awareness and participation in pharmaceutical R&D. This patient-led academy will provide scientifically reliable, objective, comprehensive information to patients on pharmaceutical R&D. It will increase the capacity of well-informed patients to be effective advocat ...
Read Project
33
Partners Participants
FINISHED
Physical Activity as a Crucial Patient Reported Outcome in COPD (PRO- ACTIVE)
Start date: Sep 1, 2009, End date: May 31, 2016,
Physical activity (PA) is essential in maintaining optimal health in chronic diseases, including COPD.More physically active patients have less hospital admissions and better survival. Validated physicalactivity monitors have become available in recent years, and together with patient report of symptomsand distress of physical (in)activity, this may form a potent new Patient Reported Outcome (PRO) ...
Read Project
20
Partners Participants
FINISHED
Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes (U-BIOPRED)
Start date: Oct 1, 2009, End date: Sep 30, 2015,
RationaleThe inability of pre-clinical studies to predict clinical efficacy is a major bottleneck in drug development. In severe asthma this bottleneck results from: a lack of useful and validated biomarkers, underperforming pre-clinical models, inadequate and incomplete sub-phenotyping, and insufficient disease understanding.HypothesisThe use of biomarker profiles comprised of various types of hi ...
Read Project
